Advertisement
Screener

PASSAGE BIO, INC. (PASG) Executive Pay versus Performance: Pay versus Performance

PASSAGE BIO, INC. Pay versus Performance

The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.

  • 2025-12-31: PEO William Chou; PEO total compensation $1.49M; PEO compensation actually paid $1.53M; Other NEO average total compensation $722.57K.
  • 2024-12-31: PEO total compensation $1.64M; PEO compensation actually paid $902.53K; Other NEO average total compensation $871.81K.
Fiscal year endPEOPEO total compensationPEO compensation actually paidOther NEO average total compensationOther NEO average compensation actually paidTotal shareholder returnPeer group total shareholder returnNet incomeCompany-selected measureProxy filed
2025-12-31William Chou$1.49M$1.53M$722.57K$618.35K$58.00-$46.00M2026-04-07
2024-12-31$1.64M$902.53K$871.81K$660.10K$56.00-$65.00M2026-04-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
IN8BIO, INC. (INAB)United States$0.012B-0.76
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23